SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 250 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,281,000 | +62.5% | 71,529 | +24.4% | 1.26% | +37.2% |
| Q1 2018 | $2,634,000 | +47.6% | 57,501 | +28.4% | 0.92% | +43.5% |
| Q4 2017 | $1,785,000 | -6.9% | 44,799 | -6.5% | 0.64% | -8.2% |
| Q3 2017 | $1,917,000 | -55.8% | 47,932 | -52.4% | 0.70% | -56.6% |
| Q2 2017 | $4,341,000 | +37.3% | 100,708 | -0.3% | 1.61% | +27.2% |
| Q1 2017 | $3,161,000 | +126.3% | 100,986 | +82.5% | 1.27% | +117.7% |
| Q4 2016 | $1,397,000 | -34.6% | 55,333 | -36.0% | 0.58% | -31.5% |
| Q3 2016 | $2,137,000 | +57.4% | 86,403 | -44.7% | 0.85% | +36.9% |
| Q3 2014 | $1,358,000 | – | 156,236 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |